Rapid Oral Fluid Screening Devices Market
Rapid Oral Fluid Screening Devices Market Study by Alcohol, Marijuana (THC), Opioids, and Cocaine for Hospitals, Private Employers, and Home Care Settings from 2023 to 2033
Analysis of Rapid Oral Fluid Screening Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Rapid Oral Fluid Screening Devices Market Outlook (2023 to 2033)
The global rapid oral fluid screening devices market accounts for a valuation of US$ 23.8 billion in 2023 and is forecasted to climb to US$ 47.3 billion by 2033-end. Fact.MR predicts global demand for rapid oral fluid screening devices to increase at a healthy 7.1% CAGR over the next ten years.
Rapid oral fluid screening devices allow a wide range of screening for the identification of drugs or other elements from oral samples. These devices are usually non-invasive in nature and this is a key aspect that is projected to uplift their demand throughout the forecast period and beyond.
Increasing alcohol consumption and surging use of illicit drugs are prime prospects that are anticipated to favor shipments of rapid oral fluid screening devices across the forecast period. Increasing investments in healthcare infrastructure development, the launch of new roadside testing initiatives, surging awareness regarding the benefits of rapid screening, growing use of rapid screening test kits by medical professionals, and expanding medical tourism activities are other factors that could benefit market development through 2033.
Surging prevalence of oral disorders and increasing preference for minimally invasive and non-invasive testing procedures are anticipated to open up new windows of opportunity for incoming as well as established rapid medical diagnostic kit suppliers over the coming years.
High spending of governments in improving road safety and implementation of mandatory drug and alcohol testing for suspected drivers by law enforcement authorities are also expected to boost rapid oral fluid screening device sales over the next ten years. On the flip side, the absence or lack of a favorable reimbursement scenario and high costs of research and development of novel rapid screening tests are anticipated to restrict overall rapid oral fluid screening device demand going forward.
Report Attributes |
Details |
|
Rapid Oral Fluid Screening Devices Market Size (2023) |
US$ 23.8 Billion |
|
Projected Market Value (2033F) |
US$ 47.3 Billion |
|
Global Market Growth Rate (2023 to 2033) |
7.1% CAGR |
|
Market Share of 6-Panel Saliva Drug Test Kits (2022) |
>25% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Pivotal Aspects Govern Rapid Oral Fluid Screening Device Sales?
“Ever-rising Incidence of Substance Abuse”
Drug abuse has become a major issue around the world in recent years and this is also a key factor that is slated to influence rapid oral fluid screening device shipments across the forecast period. Substance abuse and alcoholism are significantly more prevalent in the United States and Eastern European countries as compared to the rest of the world. Rising mortality rates due to drug abuse have pushed governments around the world to implement stringent mandates to regulate the distribution of drugs and even stricter laws to reduce substance abuse among people.
Rapid oral fluid screening devices allow faster detection of drug abuse to initiate efforts to help people battle their abuse and dependency issues. Surging demand for alcohol and drug testing around the world is also expected to uplift rapid oral fluid screening device sales over the next ten years.
Increasing popularity of telemedicine is also contributing to the increased trafficking of opioids and other drugs that could lead to substance abuse among individuals. All of the aforementioned factors are expected to result in the high use of rapid oral fluid screening devices to eradicate and manage substance and drug abuse issues in the global society.
“Increasing Number of People Driving Under Influence of Alcohol and Illicit Drugs”
Cases of driving under the influence of alcohol and illicit drugs were resulting in road accidents and to control the situation governments and law enforcement agencies around the world have been deploying rapid oral fluid screening devices for road screening. The short time for results provided by these rapid oral testing devices has proven their efficacy in combating drug-impaired driving issues.
Increasing investments by the government to promote the use of more advanced rapid oral fluid screening devices for roadside screening of drivers for drug impairment are also expected to bolster market growth in the future. Law enforcement agencies are testing new rapid screening devices that allow them to detect a variety of illicit drugs in a short period.
- In January 2023, the Police Department of Bakersfield, California, revealed that they were testing out a new rapid drug test to investigate drivers suspected to be driving under the influence. The new test was provided by Vanguard Laboratories, which is capable of detecting meth, cannabis, opioids, etc. in 3 to 5 minutes.
An exhaustive analysis of aspects such as product standards, safety regulations, pricing trends, and other factors affecting market development on a global and regional level have been listed in this latest rapid oral fluid screening devices market survey by analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
What’s Making the United Kingdom an Investment-worthy Market?
“Rising Consumption of Alcohol and Drugs in the Country”
Alcohol and drug consumption in European countries has been witnessing an upward trend in the past few years, which is expected to primarily drive rapid oral fluid screening device shipments in Europe over the coming years. The United Kingdom is anticipated to emerge as a highly remunerative space for rapid oral fluid screening device providers owing to rising cases of drug driving.
- As per an article published on volteface, on average a rise of 113% was recorded in drug-driving arrests from 2016 through 2021.
This surge in drug driving and drunk driving cases in the country is expected to bolster demand for novel roadside testing, which would subsequently favor sales of rapid oral fluid screening devices in the United Kingdom through 2033. Increasing investments in healthcare infrastructure development by public and private sectors and surging medical R&D activity are also projected to uplift the demand for rapid screening devices over the next ten years.
Why is the United States an Opportune Space for Rapid Oral Fluid Screening Device Suppliers?
“Rising Cases of Drunk Driving and Opioid Addiction”
Opioid addiction in the United States has become a major issue in the country over the past couple of decades and has also been dubbed as an epidemic citing major concerns regarding economic output and public health. Fentanyl, heroin, morphine, and codeine are some popular opioids that have influentially contributed to the opioid epidemic in the country.
- As per an article published by Council on Foreign Relations, the majority of overdose deaths recorded in the United States from the year 2000 were found to be linked to the use of opioids.
Increasing demand for drug testing in medical as well as professional establishments to curb controlled substance use and reduce mortality rates is projected to boost demand for rapid oral screening test kits in the United States throughout the forecast period and beyond. The rising number of fatalities due to drunk driving in the country is also expected to favor rapid oral fluid screening devices market development in the future.
- As per statistics provided by the National Highway Traffic Safety Administration (NHTSA) of the United States, more than 10,000 people die in drunk-driving accidents and reportedly accounted for nearly 1/3 of total traffic-related deaths in the country in 2019.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Which Form of Rapid Oral Fluid Screening Device is Highly Sought-after?
“Strips Account for Commanding Market Share”
Based on form, the rapid oral fluid screening devices market is segmented into strips, swabs, and cassettes.
The highly portable nature and minimum inconvenience for the people being tested are prime advantages that drive demand for rapid oral fluid screening strip devices. The cost-effective nature of strips also makes them a preferred choice over cassettes and swabs, especially in emerging economies with tight spending budgets. The surging use of strips in the workplace and roadside testing applications is also anticipated to favor shipments of rapid oral fluid screening strips in the future.
Competitive Landscape
Leading rapid oral fluid screening device manufacturers are investing in research to develop and launch novel testing kits and solutions as global demand rises. Rapid oral fluid screening device start-ups are also stepping into the competitive landscape with their unique rapid oral fluid screening equipment which aids in solving key issues such as drug driving and substance abuse.
- Bloonics B.V., a start-up developing diagnostic solutions for the detection of cannabinoid activity, has developed a new technology that is claimed to measure THC impairment levels more accurately. The LuciX technology was expected to estimate when the person has taken cannabis and determine the probability of their impairment at the time of taking the test. This technology could revolutionize roadside drug testing for police and other authorities.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Rapid Oral Fluid Screening Devices Industry Research Segmentation
-
By Drug Type :
- Alcohol
- Marijuana (THC)
- Opioids
- Cocaine
- Amphetamines
- Methamphetamines
- Benzodiazepines
- Others
-
By Form :
- Cassettes
- Swabs
- Strips
-
By Product :
- 1-Panel Saliva Drug Test Kits
- 4-Panel Saliva Drug Test Kits
- 5-Panel Saliva Drug Test Kits
- 6-Panel Saliva Drug Test Kits
- 7-Panel Saliva Drug Test Kits
- 8-Panel Saliva Drug Test Kits
- 9-Panel Saliva Drug Test Kits
- 10-Panel Saliva Drug Test Kits
- 12-Panel Saliva Drug Test Kits
-
By End User :
- Hospitals
- Diagnostic Laboratories
- Forensic Laboratories
- Private Employers
- Home Care Settings
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Executive Summary 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Macro-Economic Factors 3.2. Forecast Factors - Relevance & Impact 3.3. Market Dynamics 3.3.1. Drivers 3.3.2. Restraints 3.3.3. Opportunities 3.3.4. Trends 4. Key Success Factors 5. Global Market Volume Analysis 2018-2022 and Forecast, 2023-2033 5.1. Historical Market Volume (‘000 Units) Analysis, 2018-2022 5.2. Current and Future Market Volume (‘000 Units) Projections, 2023-2033 6. Global Market - Pricing Analysis 7. Global Market Value Analysis 2018-2022 and Forecast, 2023-2033 7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2018 - 2022 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023 – 2023 8.3.1. 1- Panel Saliva Drug Test Kits 8.3.2. 4- Panel Saliva Drug Test Kits 8.3.3. 5- Panel Saliva Drug Test Kits 8.3.4. 6- Panel Saliva Drug Test Kits 8.3.5. 7- Panel Saliva Drug Test Kits 8.3.6. 8- Panel Saliva Drug Test Kits 8.3.7. 9- Panel Saliva Drug Test Kits 8.3.8. 10- Panel Saliva Drug Test Kits 8.3.9. 12- Panel Saliva Drug Test Kits 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Form 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Form, 2018 - 2022 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2023 - 2033 9.3.1. Cassettes 9.3.2. Swabs 9.3.3. Strips 9.4. Market Attractiveness Analysis By Form 10. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Drug Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2018 - 2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2023 - 2023 10.3.1. Alcohol 10.3.2. Marijuana (THC) 10.3.3. Opioids 10.3.4. Cocaine 10.3.5. Amphetamines 10.3.6. Methamphetamines 10.3.7. Benzodiazepines 10.3.8. Others 10.4. Market Attractiveness Analysis By Drug Type 11. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2018 - 2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023 - 2023 11.3.1. Hospitals 11.3.2. Diagnostic Laboratories 11.3.3. Forensic Laboratories 11.3.4. Private Employers 11.3.5. Home Care Settings 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018 - 2022 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 - 2023 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Middle East and Africa (MEA) 12.3.5. East Asia 12.3.6. South Asia 12.3.7. Oceania 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018-2022 and Forecast 2023-2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product Type 13.3.3. By Form 13.3.4. By Drug Type 13.3.5. By End User 13.4. Market Attractiveness Analysis 13.5. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018-2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product Type 14.3.3. By Form 14.3.4. By Drug Type 14.3.5. By End User 14.4. Market Attractiveness Analysis 15. Europe Market Analysis 2018-2022 and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product Type 15.3.3. By Form 15.3.4. By Drug Type 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.5. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018-2022 and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product Type 16.3.3. By Form 16.3.4. By Drug Type 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.5. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018-2022 and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product Type 17.3.3. By Form 17.3.4. By Drug Type 17.3.5. By End User 17.4. Market Attractiveness Analysis 18. Oceania Market Analysis 2018-2022 and Forecast 2023-2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product Type 18.3.3. By Form 18.3.4. By Drug Type 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.5. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 - 2022 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2023 - 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Product Type 19.3.3. By Form 19.3.4. By Drug Type 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Tier Structure Analysis (2022) 20.2. Company Share Analysis, By Top Players (2022) 20.3. Competition Benchmarking 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Abbott Laboratories 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Analyst Commentary 21.2.1.4. Key Financials 21.2.1.5. Key Developments 21.2.2. Guangzhou Wondfo Biotech Co., Ltd 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Analyst Commentary 21.2.2.4. Key Financials 21.2.2.5. Key Developments 21.2.3. OraSure Technologies, Inc 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Analyst Commentary 21.2.3.4. Key Financials 21.2.3.5. Key Developments 21.2.4. Oranoxis Inc 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Analyst Commentary 21.2.4.4. Key Financials 21.2.4.5. Key Developments 21.2.5. Premier Biotech, Inc 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Analyst Commentary 21.2.5.4. Key Financials 21.2.5.5. Key Developments 21.2.6. UCP Biosciences, Inc. 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Analyst Commentary 21.2.6.4. Key Financials 21.2.6.5. Key Developments 21.2.7. SCREEN ITALIA SRL 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Analyst Commentary 21.2.7.4. Key Financials 21.2.7.5. Key Developments 21.2.8. Securetec Detektions-Systeme AG 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Analyst Commentary 21.2.8.4. Key Financials 21.2.8.5. Key Developments 21.2.9. MEDACX Ltd. 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Analyst Commentary 21.2.9.4. Key Financials 21.2.9.5. Key Developments 21.2.10. AccuBioTech Co. Ltd. 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Analyst Commentary 21.2.10.4. Key Financials 21.2.10.5. Key Developments 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 02: Global Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Region
Table 03: Global Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 04: Global Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 05: Global Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 06: Global Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 07: Global Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Region
Table 08: North America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 09: North America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 09: Latin America Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 10: North America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 11: North America Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 12: North America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 13: North America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 14: Latin America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 15: Latin America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 16: Latin America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 17: Latin America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 18: Latin America Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 19: Europe Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 20: Europe Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 21: Europe Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 22: Europe Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 23: Europe Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 24: Europe Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 25: East Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 26: East Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 27: East Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 28: East Asia Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 29: East Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 30: East Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 31: South Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 32: South Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 33: South Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 34: South Asia Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 35: South Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 36: South Asia Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 37: Oceania Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 38: Oceania Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 39: Oceania Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 40: Oceania Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 41: Oceania Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 42: Oceania Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 43: MEA Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 44: MEA Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 45: MEA Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 46: MEA Market Volume (‘000 Units) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 47: MEA Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 48: MEA Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 49: China Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 50: China Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 51: China Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 52: China Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 53: Brazil Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 54: Brazil Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 55: Brazil Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 56: Brazil Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 57: Thailand Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product Type
Table 58: Thailand Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Form
Table 59: Thailand Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
Table 60: Thailand Market Size (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (‘000 Units) Analysis , 2018-2022
Figure 02: Global Market Volume (‘000 Units) Forecast, 2023-2033
Figure 03: Cassettes, Pricing Analysis per test kit (US$), By Region, 2022
Figure 04: Cassettes, Pricing Analysis per test kit (US$), By Region, 2033
Figure 05: Swabs, Pricing Analysis per test kit (US$), By Region, 2022
Figure 06: Swabs, Pricing Analysis per test kit (US$), By Region, 2033
Figure 07: Strips, Pricing Analysis per test kit (US$), By Region, 2022
Figure 08: Strips, Pricing Analysis per test kit (US$), By Region, 2033
Figure 09: Global Market Value Analysis (US$ Mn), 2018-2022
Figure 10: Global Market Value Forecast (US$ Mn), 2023-2033
Figure 11: Global Market Absolute $ Opportunity, 2023-2033
Figure 12: Global Market Share Analysis (%), By Product Type, 2023 & 2033
Figure 13: Global Market Y-o-Y Analysis (%), By Product Type, 2023-2033
Figure 14: Global Market Attractiveness Analysis By Product Type, 2023-2033
Figure 15: Global Market Share Analysis (%), By Form, 2023 & 2033
Figure 16: Global Market Y-o-Y Analysis (%), By Form, 2023-2033
Figure 17: Global Market Attractiveness Analysis By Form, 2023-2033
Figure 18: Global Market Share Analysis (%), By Drug Type, 2023 & 2033
Figure 19: Global Market Y-o-Y Analysis (%), By Drug Type, 2023-2033
Figure 20: Global Market Attractiveness Analysis By Drug Type, 2023-2033
Figure 21: Global Market Share Analysis (%), By End User, 2023 & 2033
Figure 22: Global Market Y-o-Y Analysis (%), By End User, 2023-2033
Figure 23: Global Market Attractiveness Analysis By End User, 2023-2033
Figure 24: Global Market Share Analysis (%), By Region, 2023 & 2033
Figure 25: Global Market Y-o-Y Analysis (%), By Region, 2023-2033
Figure 26: Global Market Attractiveness Analysis, By Region, 2023-2033
Figure 27: North America Market Value Share By Country, 2023 (A)
Figure 28: North America Market Value Share, By Product Type, 2023 (E)
Figure 29: North America Market Value Share, By Form, 2023 (E)
Figure 30: North America Market Value Share, By Drug Type, 2023 (E)
Figure 31: North America Market Value Share, By End User, 2023 (E)
Figure 32: North America Market Value Analysis (US$ Mn), 2018-2022
Figure 33: North America Market Value Forecast (US$ Mn), 2023-2033
Figure 34: North America Market Attractiveness Analysis By Product Type, 2023-2033
Figure 35: North America Market Attractiveness Analysis By Form, 2023-2033
Figure 36: North America Market Attractiveness Analysis By Drug Type, 2023-2033
Figure 37: North America Market Attractiveness Analysis By End User, 2023-2033
Figure 38: North America Market Attractiveness Analysis By Country, 2023-2033
Figure 39: Latin America Market Value Share By Country, 2023 (A)
Figure 40: Latin America Market Value Share, By Product Type, 2023 (E)
Figure 41: Latin America Market Value Share, By Form, 2023 (E)
Figure 42: Latin America Market Value Share, By Drug Type, 2023 (E)
Figure 43: Latin America Market Value Share, By End User, 2023 (E)
Figure 44: Latin America Market Value Analysis (US$ Mn), 2018-2022
Figure 45: Latin America Market Value Forecast (US$ Mn), 2023-2033
Figure 46: Latin America Market Attractiveness Analysis By Product Type, 2023-2033
Figure 47: Latin America Market Attractiveness Analysis By Form, 2023-2033
Figure 48: Latin America Market Attractiveness Analysis By Drug Type, 2023-2033
Figure 49: Latin America Market Attractiveness Analysis By End User, 2023-2033
Figure 50: Latin America Market Attractiveness Analysis By Country, 2023-2033
Figure 51: Europe Market Value Share By Country, 2023 (A)
Figure 52: Europe Market Value Share, By Product Type, 2023 (E)
Figure 53: Europe Market Value Share, By Form, 2023 (E)
Figure 54: Europe Market Value Share, By Drug Type, 2023 (E)
Figure 55: Europe Market Value Share, By End User, 2023 (E)
Figure 56: Europe Market Value Analysis (US$ Mn), 2018-2022
Figure 57: Europe Market Value Forecast (US$ Mn), 2023-2033
Figure 58: Europe Market Attractiveness Analysis By Product Type, 2023-2033
Figure 59: Europe Market Attractiveness Analysis By Form, 2023-2033
Figure 60: Europe Market Attractiveness Analysis By Drug Type, 2023-2033
Figure 61: Europe Market Attractiveness Analysis By End User, 2023-2033
Figure 62: Europe Market Attractiveness Analysis By Country, 2023-2033
Figure 63: East Asia Market Value Share By Country, 2023 (A)
Figure 64: East Asia Market Value Share, By Product Type, 2023 (E)
Figure 65: East Asia Market Value Share, By Form, 2023 (E)
Figure 66: East Asia Market Value Share, By Drug Type, 2023 (E)
Figure 67: East Asia Market Value Share, By End User, 2023 (E)
Figure 68: East Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 69: East Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 70: East Asia Market Attractiveness Analysis By Product Type, 2023-2033
Figure 71: East Asia Market Attractiveness Analysis By Form, 2023-2033
Figure 72: East Asia Market Attractiveness Analysis By Drug Type, 2023-2033
Figure 73: East Asia Market Attractiveness Analysis By End User, 2023-2033
Figure 74: East Asia Market Attractiveness Analysis By Country, 2023-2033
Figure 75: South Asia Market Value Share By Country, 2023 (A)
Figure 76: South Asia Market Value Share, By Product Type, 2023 (E)
Figure 77: South Asia Market Value Share, By Form, 2023 (E)
Figure 78: South Asia Market Value Share, By Drug Type, 2023 (E)
Figure 79: South Asia Market Value Share, By End User, 2023 (E)
Figure 80: South Asia Market Value Analysis (US$ Mn), 2018-2022
Figure 81: South Asia Market Value Forecast (US$ Mn), 2023-2033
Figure 82: South Asia Market Attractiveness Analysis By Product Type, 2023-2033
Figure 83: South Asia Market Attractiveness Analysis By Form, 2023-2033
Figure 84: South Asia Market Attractiveness Analysis By Product Type, 2023-2033
Figure 85: South Asia Market Attractiveness Analysis By Form, 2023-2033
Figure 86: South Asia Market Attractiveness Analysis By Country, 2023-2033
Figure 87: Oceania Market Value Share By Country, 2023 (A)
Figure 88: Oceania Market Value Share, By Product Type, 2023 (E)
Figure 89: Oceania Market Value Share, By Form, 2023 (E)
Figure 90: Oceania Market Value Share, By Drug Type, 2023 (E)
Figure 91: Oceania Market Value Share, By End User, 2023 (E)
Figure 92: Oceania Market Value Analysis (US$ Mn), 2018-2022
Figure 93: Oceania Market Value Forecast (US$ Mn), 2023-2033
Figure 94: Oceania Market Attractiveness Analysis By Product Type, 2023-2033
Figure 95: Oceania Market Attractiveness Analysis By Form, 2023-2033
Figure 96: Oceania Market Attractiveness Analysis By Product Type, 2023-2033
Figure 97: Oceania Market Attractiveness Analysis By Form, 2023-2033
Figure 98: Oceania Market Attractiveness Analysis By Country, 2023-2033
Figure 99: Oceania Market Value Share By Country, 2023 (A)
Figure 101: MEA Market Value Share, By Product Type, 2023 (E)
Figure 102: Oceania Market Value Share, By Form, 2023 (E)
Figure 103: MEA Market Value Share, By Drug Type, 2023 (E)
Figure 104: Oceania Market Value Share, By End User, 2023 (E)
Figure 105: MEA Market Value Analysis (US$ Mn), 2018-2022
Figure 106: MEA Market Value Forecast (US$ Mn), 2023-2033
Figure 107: MEA Market Attractiveness Analysis By Product Type, 2023-2033
Figure 108: MEA Market Attractiveness Analysis By Form, 2023-2033
Figure 109: MEA Market Attractiveness Analysis By Product Type, 2023-2033
Figure 110: MEA Market Attractiveness Analysis By Form, 2023-2033
Figure 111: MEA Market Attractiveness Analysis By Country, 2023-2033
Figure 112: Global Market Value Proportion Analysis, By Emerging Countries, 2023
Figure 113: Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2023-2033
Figure 114: China Market Value Analysis (US$ Mn), 2018-2022
Figure 115: China Market Value Forecast (US$ Mn), 2023-2033
Figure 116: Brazil Market Value Analysis (US$ Mn), 2018-2022
Figure 117: Brazil Market Value Forecast (US$ Mn), 2023-2033
Figure 118: Thailand Market Value Analysis (US$ Mn), 2018-2022
Figure 119: Thailand Market Value Forecast (US$ Mn), 2023-2033
Figure 120: Global Market: Company Share Analysis Share Analysis (2022)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the rapid oral fluid screening devices market?
The global rapid oral fluid screening devices market is valued at US$ 23.8 billion in 2023.
What is the estimated revenue for the market by 2033?
Rapid oral fluid screening device sales are extrapolated to amass a revenue of US$ 47.3 billion by 2033-end.
What is the CAGR for the rapid oral fluid screening devices market?
Global shipments of rapid oral fluid screening devices are predicted to increase at 7.1% CAGR through 2033.
Which region leads global market growth?
Rapid oral fluid screening device sales in North America account for a majority share of the global market.
Who are the key players in the global rapid oral fluid screening devices market?
MEDACX Ltd., Abbott Laboratories, Oranoxis Inc., and UCP Biosciences Inc. are leading manufacturers of rapid oral fluid screening devices.
Rapid Oral Fluid Screening Devices Market